Organogenesis Holdings Inc. (ORGO): Total Assets
$598.73M
As of 2025-12-31
$406.45M
As of 2026-06-30
+10.0%
3-year compound annual growth
+15.6%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $598.73M | +20.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $497.89M | +8.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $460.02M | +2.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $449.36M | +1.4% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $443.26M | +52.7% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $290.22M | n/c | 2022-03-01, Balance as of period end |
| 2019-12-31 | $220.69M | +34.8% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $163.68M | +10.1% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $148.72M | -52.2% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $311.44M | n/a | 2018-03-14, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $598.73M | +20.3% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
| Insmed Inc (INSM) | 2025-12-31 | $2.26B | +11.8% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.93B | -12.2% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $842.81M | +25.7% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $1.06B | +84.1% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $936.02M | +1.8% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $689.80M | +21.3% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $605.19M | +1.9% |
Compare ORGO, HCM, INSM, OPK side by side · Screen every company in Pharmaceutical Preparations ↗